The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families
- PMID: 11142761
- DOI: 10.1089/10906570050501524
The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families
Abstract
The Fragile X syndrome is the most common cause of inherited mental retardation. For a female premutation carrier, the risk of having a child with a full mutation is positively correlated with the size of the premutation. The current study was performed to evaluate the risk of premutation expansion in the offspring of average-risk carriers detected by general prenatal screening. Over a 4-year period, 9,660 women underwent DNA screening for FMR1 mutation/premutation at the Tel Aviv Sourasky Medical Center. A premutation was defined as a CGG repeat number >50 in the 5' untranslated region (UTR) of exon 1 in the FMR1 gene. The study included only individuals with no family history of X-linked mental retardation or known FMR1 mutations. A premutation was found in 85 women (1 in 114), 68 of whom consented to have prenatal diagnoses in 74 pregnancies. The abnormal allele was transmitted to the offspring in 44 pregnancies. Of these, no change in allele size was noted in 35 pregnancies (79.6%), and expansion within premutation range was evident in 4 pregnancies (9%). In 5 pregnancies (11.4%), expansion to the full mutation was noted. This occurred only in carriers having more than 90 repeats. We conclude that the likelihood of Fragile X premutation expansion to full mutation is significantly lower in individuals ascertained by general prenatal carrier testing than in those from known Fragile X families.
Similar articles
-
Prenatal diagnosis of fragile X syndrome and the risk of expansion of a premutation.Clin Genet. 2000 Aug;58(2):111-5. doi: 10.1034/j.1399-0004.2000.580204.x. Clin Genet. 2000. PMID: 11005143
-
Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.Am J Hum Genet. 2001 Aug;69(2):351-60. doi: 10.1086/321974. Epub 2001 Jul 6. Am J Hum Genet. 2001. PMID: 11443541 Free PMC article.
-
Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.JAMA. 1994 Feb 16;271(7):507-14. JAMA. 1994. PMID: 8301764
-
An assessment of screening strategies for fragile X syndrome in the UK.Health Technol Assess. 2001;5(7):1-95. doi: 10.3310/hta5070. Health Technol Assess. 2001. PMID: 11262423 Review.
-
Advances in molecular analysis of fragile X syndrome.JAMA. 1994 Feb 16;271(7):536-42. JAMA. 1994. PMID: 8301769 Review.
Cited by
-
FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States.Genome Med. 2012 Dec 21;4(12):100. doi: 10.1186/gm401. eCollection 2012. Genome Med. 2012. PMID: 23259642 Free PMC article.
-
The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge.Clin Biochem Rev. 2011 Aug;32(3):135-62. Clin Biochem Rev. 2011. PMID: 21912443 Free PMC article.
-
ATR protects the genome against CGG.CCG-repeat expansion in Fragile X premutation mice.Nucleic Acids Res. 2008 Feb;36(3):1050-6. doi: 10.1093/nar/gkm1136. Epub 2007 Dec 26. Nucleic Acids Res. 2008. PMID: 18160412 Free PMC article.
-
Offering fragile X syndrome carrier screening: a prospective mixed-methods observational study comparing carrier screening of pregnant and non-pregnant women in the general population.BMJ Open. 2013 Sep 10;3(9):e003660. doi: 10.1136/bmjopen-2013-003660. BMJ Open. 2013. PMID: 24022395 Free PMC article.
-
A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.J Mol Diagn. 2008 Jan;10(1):43-9. doi: 10.2353/jmoldx.2008.070073. Epub 2007 Dec 28. J Mol Diagn. 2008. PMID: 18165273 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical